UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
11 p, 858.6 KB Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation / Baron, Frédéric (Université de Liège (Bèlgica)) ; Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ; Ruggeri, Annalisa (Hôpital Saint-Louis (Paris, França)) ; Mohty, Mohamad (Hôpital Saint-Antoine (Paris, França)) ; Sanz, Guillermo (Hospital Universitario y Politécnico La Fe (València, País Valencià)) ; Milpied, Noel (Hôpital Haut Léveque (Pessac, França)) ; Bacigalupo, Andrea (Ospedale Sant Martino (Genova, Itàlia)) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Itàlia)) ; Bonifazi, Francesca (Policlinico Sant'Orsola-Malpighi (Bologna, Itàlia)) ; Bosi, Alberto (Azienda Ospedaliero Universitaria Careggi (Firenze, Itàlia)) ; Sierra, Jorge (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Yakoub-Agha, Ibrahim (Hôpital Claude Huriez (Lille, França)) ; Ribera Santasusana, J. M. (José María) (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gluckman, Eliane (Hôpital Saint-Louis (Paris, França)) ; Nagler, Arnon (Sheba Medical Center (Ramat Gran, Israel))
BACKGROUND: In the setting of allogeneic human leukocyte antigen (HLA)-matched bone marrow transplantation, transplanting male patients with grafts from female donors has been associated with a higher incidence of graft-versus-host disease (GVHD) and of nonrelapse mortality (NRM). [...]
2015 - 10.1186/s13045-015-0207-4
Journal of hematology & oncology, Vol. 8 Núm. 107 (october 2015)  
10 p, 306.7 KB A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia : results from a randomized, double-blind, phase 2 tria / Sierra Gil, Jorge (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Szer, Jeffrey (Royal Melbourne Hospital (Melbourne, Austràlia)) ; Kassis, Jeannine (Hospital Maisonneuve-Rosemont (Montreal, Canadà)) ; Herrmann, Richard (Royal Perth Hospital (Perth, Austràlia)) ; Lazzarino, Mario (University of Pavia (Itàlia)) ; Thomas, Xavier (Edouard Herriot Hospital (Lyon, França)) ; Noga, Stephen J. (Alvin and Lois Lapidus Cancer Institute (Baltimore, Estats Units d'Amèrica)) ; Baker, Nigel (Biostatistics, Amgen Ltd. (Cambridge, Regne Unit)) ; Dansey, Roger (Clinical Development, Amgen Inc. (Thousand Oaks, Estats Units d'Amèrica)) ; Bosi, Alberto (University of Florence (Itàlia). Department of Critical Care)
Background: Patients with acute myeloid leukemia (AML) are often neutropenic as a result of their disease. Furthermore, these patients typically experience profound neutropenia following induction and/or consolidation chemotherapy and this may result in serious, potentially life-threatening, infection. [...]
2008 - 10.1186/1471-2407-8-195
BMC Cancer, Vol. 8, N. 195 (July 2008) , p. 1-10  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.